bli400
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
3
Phase 4
0
Earliest trial started May 1, 2015 (NCT02481947)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bli400
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02819297 | Phase 3 | Jun 1, 2016 | Braintree Laboratories |
| NCT02819310 | Phase 3 | Jun 1, 2016 | Braintree Laboratories |
| NCT02665728 | Phase 2 | Dec 1, 2015 | Braintree Laboratories |
| NCT02481947 | Phase 3 | May 1, 2015 | Braintree Laboratories |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Braintree Laboratories | For profit | 4 | 4 | 2 | 2015 |
1 organizations
Page 1 / 1